[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

Complete article - Doctor reflects on treating Tokaimura nuclear-accident victim



Below is the full article, cut short by the word "from"

Doctor reflects on treating Tokaimura nuclear-accident victim

TOKYO, Jan. 24 (Kyodo) - The chief physician who treated the first 
person in Japan to die from a nuclear power-related accident said 
Monday that support from fellow doctors as well as the patient's 
family helped his team through the difficult case. 

Kazuhiko Maekawa, a professor at the University of Tokyo Hospital, 
also said the kind of treatment given to Hisashi Ouchi, who died last 
month as a result of massive exposure to radiation in the Sept. 30 
nuclear accident in Tokaimura, Ibaraki Prefecture, was completely new 
to him. 

''It was the first time I experienced such a case in my 30-plus years 
as a doctor,'' Maekawa, 58, told Kyodo News. 

''Almost every day, we came across situations that were not covered 
in medical textbooks, and there were tough moments in continuing 
treatment without any sign of a way out,'' he added. 

Ouchi, who died of multiple organ failure Dec. 21 at age 35, was 
exposed to an estimated 17 sieverts of radiation when he and a fellow 
worker poured too much uranium into a processing tank at a nuclear 
fuel processing plant run by JCO Co., triggering a self-sustaining 
nuclear fission reaction. 

The level of radiation Ouchi was exposed to is said to be almost the 
same as at the blast centers in the 1945 nuclear bombings of 
Hiroshima and Nagasaki and about 17,000 times the maximum annual 
permissible exposure in Japan. 

Maekawa said he was encouraged by the support he and his team of 
doctors received over nearly three months of attempts to improve 
Ouchi's condition. 

''We were able to gain technical cooperation from expert doctors from 
various regions as well as have medicine sent to us directly from 
abroad. The government also backed us up, saying we should provide as 
much treatment as possible,'' he said. 

The patient's family was also a source of support for Maekawa's team, 
which began treating Ouchi after he was transferred to the University 
of Tokyo Hospital on Oct. 2 -- two days after the accident. 

''The family's attitude was also very helpful. Even when the patient 
fell into critical condition, they never gave up hope and I think 
that showed how much the family wanted Mr. Ouchi to keep living. 
There were many things I learned from them,'' the doctor said. 

"From" a medical point of view, Maekawa said, the experience of 
treating Ouchi will provide useful information to doctors 
specializing in treating victims of radiation. 

''It will take some time before the report on Mr. Ouchi's autopsy is 
finalized, but I want to compile a database of the valuable medical 
data we will gain from the report as well as data from the course of 
treatment, and make it available worldwide,'' he said. 

Regarding calls to reinforce safety measures and medical systems for 
nuclear disasters in the aftermath of Japan's worst nuclear accident, 
Maekawa stressed that emphasis should be placed first and foremost on 
the protection of human life. 

He added that as long as Japan continues to rely on nuclear energy, 
there needs to be an organization that specializes in the treatment 
of radiation victims. About one-third of Japan's electric power 
supply is generated from atomic power. 

The Tokaimura accident exposed at least 69 people, including Ouchi, 
to more than normal levels of radiation. Another JCO worker, Masato 
Shinohara, 40, remains hospitalized after being exposed to an 
estimated 8 sieverts of radiation in the incident. 

------------------------------------------------------------------------
Sandy Perle					Tel:(714) 545-0100 / (800) 548-5100   				    	
Director, Technical				Extension 2306 				     	
ICN Worldwide Dosimetry Division		Fax:(714) 668-3149 	                   		    
ICN Biomedicals, Inc.				E-Mail: sandyfl@earthlink.net 				                           
ICN Plaza, 3300 Hyland Avenue  		E-Mail: sperle@icnpharm.com          	          
Costa Mesa, CA 92626                                      

Personal Website:  http://www.geocities.com/scperle
ICN Worldwide Dosimetry Website: http://www.dosimetry.com

************************************************************************
The RADSAFE Frequently Asked Questions list, archives and subscription
information can be accessed at http://www.ehs.uiuc.edu/~rad/radsafe.html